Published in Can J Neurol Sci on February 01, 1991
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72
Amyotrophic lateral sclerosis. Orphanet J Rare Dis (2009) 2.76
Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc Natl Acad Sci U S A (2009) 1.59
British motor neuron disease twin study. J Neurol Neurosurg Psychiatry (1997) 1.25
Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet (1998) 1.19
Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet (1995) 0.94
Review on intermediate filaments of the nervous system and their pathological alterations. Histochem Cell Biol (2013) 0.92
Amyotrophic Lateral Sclerosis. Curr Treat Options Neurol (2000) 0.79
Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet (1993) 2.56
Ferritin mutants of Escherichia coli are iron deficient and growth impaired, and fur mutants are iron deficient. J Bacteriol (1999) 2.37
Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain (1992) 2.33
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain (1981) 2.15
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03
The development of erectile dysfunction in men treated for prostate cancer. J Urol (2001) 1.97
Frontal lobe atrophy in motor neuron diseases. Brain (1994) 1.76
Evaluation of six screening methods for detecting significant bacteriuria. J Clin Pathol (1988) 1.74
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer Inst (1999) 1.61
Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2. J Clin Oncol (1993) 1.46
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma. Cancer Invest (1998) 1.39
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res (1993) 1.34
Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res (1995) 1.33
Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples. J Clin Microbiol (1999) 1.25
The high-resolution X-ray crystallographic structure of the ferritin (EcFtnA) of Escherichia coli; comparison with human H ferritin (HuHF) and the structures of the Fe(3+) and Zn(2+) derivatives. J Mol Biol (2001) 1.22
Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci U S A (2001) 1.21
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res (1996) 1.21
The muscular pain-fasciculation syndrome. Neurology (1978) 1.14
HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1994) 1.14
Interspecific backcross mice show sex-specific differences in allelic inheritance. Genetics (1991) 1.13
Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis (1995) 1.13
Effects of subtle changes in the SU protein of ecotropic murine leukemia virus on its brain capillary endothelial cell tropism and interference properties. Virology (1996) 1.12
Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab (1997) 1.12
Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain (1991) 1.10
Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun (1998) 1.10
Bell-inequality violation with a triggered photon-pair source. Phys Rev Lett (2009) 1.08
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. J Clin Oncol (1990) 1.06
Fibrinogen induces IL-8 synthesis in human neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine or leukotriene B(4). J Immunol (2001) 1.05
Direct observation of the iron binding sites in a ferritin. FEBS Lett (1994) 1.03
Iron incorporation into ferritins: evidence for the transfer of monomeric Fe(III) between ferritin molecules and for the formation of an unusual mineral in the ferritin of Escherichia coli. Biochem J (1994) 0.95
Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet (1992) 0.95
Biochemical changes in denervated skeletal muscle. 3. The effect of denervation atrophy on the concentration and 32P labelling of the individual phospholipids of the rat gastrocnemius. Biochim Biophys Acta (1965) 0.94
Gerstmann-Sträussler-Scheinker disease: autopsy study of a familial case. Ann Neurol (1986) 0.91
Alteration of Met protooncogene product expression and prognosis in breast carcinomas. Anal Quant Cytol Histol (1999) 0.90
T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. J Immunol (1998) 0.90
Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects. Cancer Res (1992) 0.89
Ras oncogene-induced sensitization to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1999) 0.89
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin. N Engl J Med (1993) 0.89
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge. AIDS Res Hum Retroviruses (2001) 0.89
Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma. J Immunother Emphasis Tumor Immunol (1993) 0.89
Changes in shapes of surviving motor neurons in amyotrophic lateral sclerosis. Brain (1993) 0.88
Dose-related immunologic effects of levamisole in patients with cancer. J Clin Oncol (1993) 0.87
Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers. Cancer Epidemiol Biomarkers Prev (2000) 0.87
Pain perception and response: central nervous system mechanisms. Can J Neurol Sci (2000) 0.87
Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Dev (1997) 0.86
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer. J Clin Oncol (1998) 0.86
Myopathy in primary familial hyperparathyroidism. Clinical and morphologic studies. Am J Med (1970) 0.85
Conditioned immune response to interferon-gamma in humans. Clin Immunol (1999) 0.85
Biochemical changes in denervated skeletal muscle. I. The effect of denervation atrophy on the main phosphate fractions of the rat-gastrocnemius muscle. Biochim Biophys Acta (1965) 0.84
Development of a nanoscale liquid chromatography/electrospray mass spectrometry methodology for the detection and identification of DNA adducts. Anal Chem (1997) 0.84
Triglyceride metabolism in skeletal muscle from normal and dystrophic mice. Biochim Biophys Acta (1974) 0.84
Studies on insulin resistance and insulin receptor binding in myotonia dystrophica. J Clin Endocrinol Metab (1979) 0.84
Segmental myofiber necrosis in myotonic dystrophy - An immunoperoxidase study of immunoglobulins in skeletal muscle. Am J Pathol (1983) 0.83
Fatty acid metabolism in dystrophic muscle in vitro. Life Sci (1969) 0.83
Changes in the relative amounts of ascorbic acid and glycogen in denervated rat gastrocnemius muscle. Can J Biochem (1965) 0.83
Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. Virology (1998) 0.82
Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. J Mol Endocrinol (2004) 0.82
The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada. Neurology (1986) 0.82
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia. Cancer J Sci Am (2000) 0.82
Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer. Clin Cancer Res (1996) 0.81
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques. AIDS (2000) 0.81
Gerstmann-Sträussler-Scheinker disease with coincidental familial onset. Ann Neurol (1983) 0.81
Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques. Proc Natl Acad Sci U S A (1998) 0.80
Hyperinsulinemia in myotonic dystrophy: identity of the maternal factor causing the neonatal myotonic dystrophy syndrome. Med Hypotheses (1985) 0.80
Carbohydrate metabolism and insulin resistance in myotonia dystrophica. J Clin Endocrinol Metab (1977) 0.80
The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy. Brain (1987) 0.80
Otolaryngologic manifestations of amyotrophic lateral sclerosis. J Otolaryngol (1988) 0.80
Primary malignant melanomatosis of leptomeninges. Arch Neurol (1966) 0.79
Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma. J Natl Cancer Inst (1996) 0.79
Motor-evoked responses in primary lateral sclerosis. Muscle Nerve (1992) 0.79
Activities of enzymes of the citric acid cycle and electron transport chain in the skeletal muscle of normal and dystrophic mice (strain 129). Enzyme (1972) 0.79
Preservation of certain voluntary muscles in motoneurone disease. Lancet (1988) 0.79
Acetyl-1- 14 C-l-carnitine oxidation, carnitine acetyltransferase activity, and CoA content in skeletal muscle mitochondria from normal and dystrophic mice (strain 129). Can J Biochem (1972) 0.78
Palmitic acid-1- 14 C oxidation by skeletal muscle mitochondria of dystrophic mice. Can J Biochem (1970) 0.78
Anti-neurone antibodies are not characteristic of amyotrophic lateral sclerosis. Neuroreport (1993) 0.78
Monocyte IgG-Fc receptors in myotonic dystrophy. Clin Exp Immunol (1982) 0.78
Insulin binding to myotonic dystrophy fibroblasts. J Neurol Sci (1983) 0.78
Adenyl cyclase and cyclic nucleotide phosphodiesterase activities in murine muscular dystrophy. Enzyme (1976) 0.77
Biphoton interference with a quantum dot entangled light source. Opt Express (2007) 0.77
Biochemical studies in dystrophic mouse muscle. Ann N Y Acad Sci (1979) 0.77
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts. J Cancer Res Clin Oncol (1998) 0.77
Regulation of glycogen synthesis in human skeletal muscle: does cellular glycogen control glycogen synthase phosphatase activity? Biochem Int (1991) 0.77
Observation of the binary coalescence and equilibration of micrometer-sized droplets of aqueous aerosol in a single-beam gradient-force optical trap. J Phys Chem A (2012) 0.76
Motor unit estimates in the biceps-brachialis in amyotrophic lateral sclerosis. Muscle Nerve (1988) 0.76
Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients. Clin Immunol (1999) 0.76
Perseveration. Brain (1968) 0.76
Alkylation of DNA in rats by N-nitrosomethyl-(2-hydroxyethyl)amine: dose response and persistence of the alkylated lesions in vivo. Cancer Res (1988) 0.76
Amyotrophic lateral sclerosis: concepts in pathogenesis and etiology. Can J Neurol Sci (1987) 0.76
Aphasic dementia and motor neuron disease. Ann Neurol (1993) 0.76
Kinetics of recovery of CD4+ T cells in peripheral blood of deoxycoformycin-treated patients. J Natl Cancer Inst (1991) 0.75
Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer. J Immunother Emphasis Tumor Immunol (1996) 0.75
Comparison of the intermediary metabolism of fatty acids in denervated and dystrophic murine skeletal muscle. J Neurol Neurosurg Psychiatry (1975) 0.75
RFLP for BglII at the human skeletal muscle sodium channel locus. Nucleic Acids Res (1991) 0.75
Guam ALS-PDC: possible causes. Science (1993) 0.75
Fatty acid oxidation by skeletal muscle mitochondria in Duchenne muscular dystrophy. Life Sci II (1972) 0.75